TAPP Signs Coalition Letter Opposing Prescription Drug Price Controls

TAPP is one of forty-one associations across the country that joined in sending a letter to Speaker Johnson and Leader McConnell in opposition to the Inflation Reduction Act’s prescription drug price controls.

The letter said, in part, "Instead of hiring more bureaucrats to set up a new price control board, Congress should work to lower Medicare premiums, increase plan choices, and require insurers and pharmacy benefit managers to share discounts, rebates, and savings with patients. It's also time that lawmakers take a hard look at foreign countries who are buying U.S.-developed medicines for pennies on the dollar. American patients shouldn't be subsiding the rest of the world's access to medicines."

Read the full letter here.